AI transforming pharma
This event, co-organised by The Singaporean-German Chamber of Industry and Commerce Healthcare & Life Sciences Committee, and The French Chamber of Commerce will bring together experts across R&D, manufacturing, and regulatory affairs to explore how AI is being used to drive innovation, ensure compliance, and improve patient outcomes.
Key topics will include:
- AI in Drug Discovery & Development: Target identification, predictive modeling, and AI-driven clinical trial design
- AI in Quality Assurance & Manufacturing: Real-time monitoring, automated inspection, and process optimization
- AI in Regulatory Affairs: Regulatory perspectives on AI/ML, intelligent submission preparation, and audit readiness
- Data Integrity & Model Governance: Ensuring data quality, model validation, and ethical AI use
- Case Studies & Future Trends: Real-world success stories and the evolving role of AI in personalized medicine
Whether you're in pharma, biotech, quality, or regulatory affairs, this event will offer actionable insights to help you leverage AI across the drug development lifecycle—safely, effectively, and compliantly.
Speakers
- Dr Karin Markgraf, SGC Co-Chairperson Healthcare & Life Sciences Committee, Head of Regulatory Affairs Asia Pacific at Merck Group
- Damien Keogh, Founder at BlueMaiden Biosciences
- Maria Aileen Mabunay, Global Medical Lead at Sanofi
Moderator
- Maximilian Englisch, SGC Co-Chairperson Healthcare & Life Sciences Committee, Global Vice-President of Sales at WALDNER Group
REGISTER HERE
Please note registration is via the French Chamber's Website